This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Packaging and labeling of cannabis-infused edibles are unregulated at the federal level due to Cannabis remaining a Schedule I drug. The cannabis industry must comply with individual state codes and uses international standards for guidance. Cannabis-infused edibles are packaged and labeled with all the familiar requirements for a food and dietary supplement, and further requirements must be met—for example, child-resistant packaging and the labeling of warnings.
A recent study has found pervasive, low levels of lead, cadmium, arsenic, mercury, and phthalates in U.S. cannabidiol products. The study also demonstrated substantial inaccuracies of product label claims for CBD potency.
The U.S. Food and Drug Administration (FDA) recently announced that consumers should not ingest any marijuana-infused products that contain delta-8 THC, aka delta-8 tetrahydrocannabinol.